Abstract

BackgroundA high SUV-reproducibility is crucial when different PET scanners are in use. We evaluated the SUV variability in whole-body FDG-PET scans of patients with suspected or proven cancer using an EARL-accredited conventional and digital PET scanner.In a head-to-head comparison we studied images of 50 patients acquired on a conventional scanner (cPET, Ingenuity TF PET/CT, Philips) and compared them with images acquired on a digital scanner (dPET, Vereos PET/CT, Philips). The PET scanning order was randomised and EARL-compatible reconstructions were applied.We measured SUVmean, SUVpeak, SUVmax and lesion diameter in up to 5 FDG-positive lesions per patient. The relative difference ΔSUV between cPET and dPET was calculated for each SUV-parameter. Furthermore, we calculated repeatability coefficients, reflecting the 95% confidence interval of ΔSUV.ResultsWe included 128 lesions with an average size of 19 ± 14 mm. Average ΔSUVs were 6-8% with dPET values being higher for all three SUV-parameters (p < 0.001). ΔSUVmax was significantly higher than ΔSUVmean (8% vs. 6%, p = 0.002) and than ΔSUVpeak (8% vs. 7%, p = 0.03). Repeatability coefficients across individual lesions were 27% (ΔSUVmean and ΔSUVpeak) and 33% (ΔSUVmax) (p < 0.001).ConclusionsWith EARL-accredited conventional and digital PET, we found a limited SUV variability with average differences up to 8%. Furthermore, only a limited number of lesions showed a SUV difference of more than 30%. These findings indicate that EARL standardisation works.Trial registrationThis prospective study was registered on the 31th of October 2017 at ClinicalTrials.cov. URL: https://clinicaltrials.gov/ct2/show/NCT03457506?id=03457506&rank=1.

Highlights

  • A high Standardised uptake value (SUV)-reproducibility is crucial when different Positron emission tomography (PET) scanners are in use

  • A recent evaluation among the first 200 accredited systems from 150 sites worldwide showed that setting up a harmonising accreditation program is feasible and achievable, and that the FDG-PET/Computed tomography (CT) program has reduced the variability in semi-quantitative PET performance [3]

  • Only a limited number of lesions showed a SUV difference of more than 30%. These findings indicate that EANM Research Ltd. (EARL) standardisation works

Read more

Summary

Introduction

We evaluated the SUV variability in whole-body FDG-PET scans of patients with suspected or proven cancer using an EARL-accredited conventional and digital PET scanner. Positron emission tomography/computed tomography (PET/CT) using fluor-18 fluorodeoxyglucose (FDG) is widely used for tumour imaging in patients with cancer. There are ongoing efforts towards standardisation of FDG-PET imaging to allow a quantitative comparison between patients, scanners and medical centres. In 2009 and 2015 the European Association of Nuclear Medicine (EANM) published procedure guidelines on FDG-PET/ CT tumour imaging [1, 2]. In 2010, EARL started an accreditation program for FDG-PET/CT tumour imaging. This includes EARLaccreditation requirements based on activity concentration recovery coefficients (CRCs) as measured in PET images of a NEMA NU2-2001 image quality phantom. A recent evaluation among the first 200 accredited systems from 150 sites worldwide showed that setting up a harmonising accreditation program is feasible and achievable, and that the FDG-PET/CT program has reduced the variability in semi-quantitative PET performance [3]

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.